Home › GUJALKALI › Filing
🔔 Get instant alerts when GUJALKALI files quarterly results on BSE Start free trial →

Outcome of Board Meeting

Filed: 05 Nov 2026, 12:33 IST Exchange: NSE Category: Financial Results — Audited Results
Q2FY27 results (unaudited): Standalone: Revenue 1.36bn +25% y-y (1.08bn) PAT 0.079bn +386% y-y (0.016bn) Consolidated: Revenue 1.36bn +25% y-y (1.08bn) PAT 0.083bn +406% y-y (0.016bn) H1FY27 results (unaudited): Standalone: Revenue 2.60bn +19% y-y (2.19bn) PAT 0.133bn +452% y-y (0.024bn) Consolidated: Revenue 2.60bn +19% y-y (2.19bn) PAT 0.138bn +539% y-y (0.003bn) FY26 results (audited): Standalone: Revenue 4.36bn PAT 0.021bn Consolidated: Revenue 4.36bn PAT -0.002bn Dividend: 17.70/share (record date 25th September, 2026) Commentary: Board approved standalone and consolidated unaudited financial results for Q2 and H1 ended 30th September 2026; dividend declared for FY26.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 GUJALKALI — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GUJALKALI to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Gujarat Alkalies and Chemicals Limited

Important. The summary above is generated automatically from Gujarat Alkalies and Chemicals Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.